{"id":728990,"date":"2023-02-06T16:12:29","date_gmt":"2023-02-06T21:12:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/"},"modified":"2023-02-06T16:12:29","modified_gmt":"2023-02-06T21:12:29","slug":"emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/","title":{"rendered":"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">GAITHERSBURG, Md., Feb.  06, 2023  (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, February 27, 2023, at 5:00 pm eastern time to discuss the financial results for the fourth quarter of 2022, recent business developments, and financial outlook for full year 2023.<\/p>\n<p>\n        <strong>Conference Call Information<\/strong><br \/>\n        <br \/>Participants can access the conference call live via webcast from the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TEccup5tplTd1KvXl4dTnte6jm-1oxSMbyw92eFr7Q4rt39zIh4QL6dT_ufmo4zF6bvncsdwFXe-Sgz-kbCa_AFpJ4WiK1EGvquqoCEL1Hg=\" rel=\"nofollow noopener\" target=\"_blank\">Investors<\/a> page of Emergent\u2019s website. To participate via telephone, please register in advance at this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4g99Xl_xf-5FmHJTWCB3rzVHWQCHF03nwMK4nIqj5S6ETWUj2zYhf9K0ln1HSYLTF4a9KeFdxYFpwRNaxqwbuSuBFXyB8pLtpGy_Avg2KKOCZMuxj70CbHlzRb7hQa7V-JvqK974TChJwPzXqYPKAw==\" rel=\"nofollow noopener\" target=\"_blank\">link<\/a>. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.<\/p>\n<p>A replay of the call can be accessed from the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TEccup5tplTd1KvXl4dTnj17UdgNWFA08xAydUuVvYRl4B0-nlZJUgol8G16criCk8rTZulMt8O_szC615E07YhIE4W2al4p7p7W4PNpVMo=\" rel=\"nofollow noopener\" target=\"_blank\">Investors<\/a> page of Emergent\u2019s website.<\/p>\n<p>\n        <strong>About Emergent BioSolutions<\/strong><br \/>\n        <br \/>At Emergent, our mission is to protect and enhance life. For over 20 years, we\u2019ve been at work defending people from things we hope will never happen\u2014so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=crWw8jq_elDUv9UY7vdPFWZleWS7wpGmAhSTGrrZJkvlXVhMHWFbuxouXiIiJEBIR_v4Qkjh8AS9yJC689tkWQ==\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ag7nH1oj4oGV7F2TLeFF2dywvy9p6Li-SfbuWUjBT9VGXabPMDqHvaDj3HeUwSH6fajgU-bgyyqqjfzjBg5scyWUBqtovrRVOO68wrayWv-hPkW5uodj1wNeujPYn0qC\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dukX502J8a5J2YocTqNULyZJsclTQE0f5BvfZDBzjBzE5o-VjKMU6ZKOrUSgWs5AnHGl6W5HSidtwWwERylMjw==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F69U9sSizV4JmKqjRSJ1YY2rdZeSdGE8MrhZurrq6GXQS6s5DbW0c7G9xTbPBPyCYvjfl7tmhN5QAtLwLrHzOf3tUTZHJJSrgt81_1JRNXM=\" rel=\"nofollow noopener\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Robert G. Burrows<br \/>Vice President, Investor Relations<br \/>240-631-3280<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HesggqQ_60yCdVg0FPKwpX1gcxxM-HtwYg3NwDnQtUCnRYidAorIXCU1WkLT7qs3Rd7sLVYVGAf2g8kULjfqFQ==\" rel=\"nofollow noopener\" target=\"_blank\">burrowsr@ebsi.com<\/a>\u00a0\u00a0<\/p>\n<p align=\"left\">\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Matt Hartwig<br \/>Senior Director, Media Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BMMAz7oN7eBd73b6e6gu_Pb09KldjvasvCh9AIX-H9SVcNwaL0ivc_0J7KZnk15cst6ly-wMq0bMGB61nyFF8bsuXUmwdPkQ5TQmvi4Ev04=\" rel=\"nofollow noopener\" target=\"_blank\">mediarelations@ebsi.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTQ5ZGVhNWQtNjlkNi00NWFjLTlmMzEtZTYwY2EzZjgyZjYyLTEwMjI0Mzk=\/tiny\/Emergent-Biosolutions-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GAITHERSBURG, Md., Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, February 27, 2023, at 5:00 pm eastern time to discuss the financial results for the fourth quarter of 2022, recent business developments, and financial outlook for full year 2023. Conference Call Information Participants can access the conference call live via webcast from the Investors page of Emergent\u2019s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-728990","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, February 27, 2023, at 5:00 pm eastern time to discuss the financial results for the fourth quarter of 2022, recent business developments, and financial outlook for full year 2023. Conference Call Information Participants can access the conference call live via webcast from the Investors page of Emergent\u2019s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the &hellip; Continue reading &quot;Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-06T21:12:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023\",\"datePublished\":\"2023-02-06T21:12:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/\",\"name\":\"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=\",\"datePublished\":\"2023-02-06T21:12:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/","og_locale":"en_US","og_type":"article","og_title":"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023 - Market Newsdesk","og_description":"GAITHERSBURG, Md., Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, February 27, 2023, at 5:00 pm eastern time to discuss the financial results for the fourth quarter of 2022, recent business developments, and financial outlook for full year 2023. Conference Call Information Participants can access the conference call live via webcast from the Investors page of Emergent\u2019s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the &hellip; Continue reading \"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-06T21:12:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023","datePublished":"2023-02-06T21:12:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/","name":"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=","datePublished":"2023-02-06T21:12:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzY4MCM1Mzk0MTU5IzIwMTA4NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-release-fourth-quarter-2022-financial-results-and-conduct-conference-call-on-february-27-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Emergent BioSolutions to Release Fourth Quarter 2022 Financial Results and Conduct Conference Call on February 27, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=728990"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728990\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=728990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=728990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=728990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}